KEVIN SALAS: Open Payments
NPI 1497166045 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 12 payments from 6 companies in 2025. Trend: 2023 $67 · 2024 $50 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 3 | $86 |
| Lilly USA, LLC | 3 | $56 |
| Novo Nordisk Inc | 3 | $50 |
| Ardelyx, Inc. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Globus Medical, Inc. | 1 | $21 |
Products named: Omnipod, IBSRELA, MOUNJARO, JARDIANCE, TRINTELLIX, Senza, Ozempic, Rybelsus.
Industry payments across TX — which companies pay providers there.
